An enzyme inhibitor is a molecule that reduces or stops enzyme activity without permanently destroying the enzyme. Competitive inhibitors block the active site directly; non-competitive (allosteric) inhibitors bind elsewhere on the enzyme, changing its shape so the substrate can no longer fit. Both types are exploited in medicines, pesticides and the body's own metabolic regulation.
What is enzyme inhibition?
Recall that enzyme activity depends on the complementary shape between the active site and the substrate. Any molecule that interferes with this relationship reduces the rate of reaction.
Key vocabulary:
- Inhibitor: a molecule that reduces enzyme activity.
- Reversible inhibitor: binds temporarily; enzyme activity recovers when the inhibitor is removed.
- Irreversible inhibitor: permanently alters the active site; activity cannot recover.
At GCSE, most examination questions focus on reversible inhibitors. Irreversible inhibitors (such as nerve agents that permanently block acetylcholinesterase) represent an extreme case.
How does a competitive inhibitor work?
A competitive inhibitor has a shape similar to the substrate. It competes with the substrate for the same active site:
- The inhibitor enters the active site and binds to it.
- While it is bound, the substrate cannot enter.
- No enzyme-substrate complex forms → no product is made.
- The inhibitor eventually leaves, and the active site is available again.
Effect on rate: competitive inhibition can be overcome by increasing substrate concentration. With more substrate molecules competing, the inhibitor is statistically displaced more frequently. At very high substrate concentrations, the inhibition is almost fully reversed and the reaction rate approaches its uninhibited maximum.
Example: Methotrexate competitively inhibits dihydrofolate reductase (an enzyme in DNA synthesis), used in cancer chemotherapy. Malonate competitively inhibits succinate dehydrogenase in the Krebs cycle.
How does a non-competitive inhibitor work?
A non-competitive (or allosteric) inhibitor binds at a different site on the enzyme — the allosteric site — not the active site.
- The inhibitor binds at the allosteric site.
- This changes the three-dimensional shape of the enzyme.
- The active site distorts, becoming a different shape — no longer complementary to the substrate.
- Even with high substrate concentrations, the substrate cannot fit the changed active site.
Effect on rate: unlike competitive inhibition, non-competitive inhibition cannot be overcome by increasing substrate concentration. The maximum rate achievable is permanently lower as long as the inhibitor is present.
Example: Some pesticides act as non-competitive inhibitors of acetylcholinesterase in insect nervous systems.
How do competitive and non-competitive inhibition compare?
| Feature | Competitive inhibition | Non-competitive inhibition |
|---|---|---|
| Binding site | Active site | Allosteric site (different from active site) |
| Shape similarity to substrate | Yes — similar shape needed | No — binds elsewhere |
| Effect on active site | Blocks access directly | Distorts active site indirectly |
| Reversible by adding more substrate? | Yes | No |
| Effect on maximum reaction rate | Rate can still reach uninhibited maximum at high [S] | Maximum rate is reduced |
How does inhibition appear on rate-of-reaction graphs?
Without inhibitor: as substrate concentration increases, rate increases and levels off at Vmax (maximum velocity, when all active sites are occupied).
With competitive inhibitor (at the same inhibitor concentration):
- Rate is lower at each substrate concentration.
- But at very high substrate concentrations, rate approaches the same Vmax.
With non-competitive inhibitor:
- Rate is lower at every substrate concentration.
- The curve levels off at a lower Vmax — the maximum is never reached, regardless of substrate concentration.
Worked example: An enzyme has Vmax = 40 μmol/min uninhibited. With a competitive inhibitor, raising [S] sufficiently still approaches 40 μmol/min. With a non-competitive inhibitor, the maximum achievable rate might be only 20 μmol/min even at saturating [S].
Where are enzyme inhibitors important in biology and medicine?
| Context | Inhibitor | Enzyme inhibited | Effect |
|---|---|---|---|
| Medicine | Aspirin | Cyclooxygenase (COX) | Reduces prostaglandin synthesis → anti-inflammatory, pain relief |
| Medicine | Statins | HMG-CoA reductase | Reduces cholesterol synthesis → lowers cardiovascular risk |
| Pesticides | Organophosphates | Acetylcholinesterase | Blocks nerve signal termination in insects |
| Metabolic regulation | End-product inhibition | Many biosynthetic enzymes | When enough product is made, it inhibits the enzyme that made it — a built-in off switch |
End-product inhibition is a particularly elegant example of non-competitive inhibition in normal metabolism: when the cell has sufficient quantities of a molecule, that molecule inhibits an early enzyme in the pathway that produces it, automatically switching off production.
Frequently asked questions
Why can competitive inhibition be reversed by adding more substrate but non-competitive inhibition cannot?
In competitive inhibition, the inhibitor and substrate compete for the same binding site. If the concentration of substrate is greatly increased, substrate molecules statistically win more often — they are more likely to occupy the active site before the inhibitor does. At very high substrate concentrations, the inhibitor is almost never in the active site. In non-competitive inhibition, the inhibitor binds at a completely different site, so adding more substrate does not dislodge it. The active site shape remains distorted regardless of how much substrate is present.
How does aspirin act as an enzyme inhibitor?
Aspirin (acetylsalicylic acid) is an irreversible competitive inhibitor of cyclooxygenase (COX) enzymes. These enzymes catalyse the first step in prostaglandin synthesis. Prostaglandins are signalling molecules that promote inflammation, fever and pain sensitivity. By blocking COX, aspirin reduces prostaglandin production, explaining its anti-inflammatory, antipyretic (fever-reducing) and analgesic (pain-reducing) effects. Aspirin's inhibition is irreversible because it chemically modifies the COX enzyme by acetylation, attaching an acetyl group to a serine residue in the active site.
What is the difference between an inhibitor and a denatured enzyme?
Inhibition is usually reversible and does not permanently alter the enzyme's primary structure. When the inhibitor dissociates, the enzyme regains its original shape and function. Denaturation, caused by extremes of temperature or pH, permanently changes the shape of the enzyme because the hydrogen bonds and other interactions maintaining its tertiary structure are broken. A denatured enzyme cannot be reactivated — its active site is irreversibly altered. Inhibition is a specific, targeted effect; denaturation is a global, non-specific collapse of protein structure.
How is end-product inhibition useful in cells?
Metabolic pathways must be carefully regulated to avoid producing more of a substance than the cell needs, which would waste raw materials and ATP. End-product inhibition (feedback inhibition) solves this elegantly: the final product of a pathway acts as a non-competitive inhibitor of the first enzyme in the pathway. When enough product accumulates, production slows automatically. When product is used up, inhibition decreases and production increases again. This self-regulating loop requires no external signal and maintains metabolite concentrations within a narrow range — an example of homeostasis at the molecular level.
For Socratic GCSE biology with Professor Darwin — investigating enzyme inhibitors from molecular mechanism to pharmaceutical application — visit aitutors.me.